NDC 49884-323-52 - Olanzapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-323
- Requested NDC
- 49884-323-52
- Package NDCs from labels
- 49884-323-52, 49884-323-55
- Manufacturer
- Par Pharmaceutical, Inc.
- Effective date
- 2021-07-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olanzapine - Par Pharmaceutical, Inc. | Par Pharmaceutical, Inc. | 2021-07-27 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49884-323-52 | EA - Each | 49884-323 | 93c1d39b-8327-4b39-b1a8-d422efcb9709 | 1 | 2013-02-13 |
| 49884-323-55 | EA - Each | 49884-323 | c314965e-112b-460a-a9e2-9e55dca92cb1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| MAGNESIUM SULFATE, UNSPECIFIED | INACTIVE INGREDIENT | DE08037SAB | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | NorthStar RxLLC | f4e41c2c-d32d-40c2-8afb-b6df998ba6b0 | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Braintree Laboratories, Inc. | 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Affordable Pharmaceuticals, LLC | f86bdcc8-e643-4160-89ae-01c89bee842d | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Family Dollar (FAMILY WELLNESS) | 7de802aa-6c31-451c-995c-8549b2545c69 | 2026-10-07 | Warnings | DE08037SAB |
| Epsom Salt | EPSOM SALT | P & L Development, LLC | a343bb9f-0b63-4464-99a0-f7137cd2125a | 2026-10-07 | Warnings | DE08037SAB |
| Zyprexa | OLANZAPINE | H2-Pharma LLC | b418946a-1ab4-4d89-a012-d94fc361a3c4 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Epsom Salt | MAGNESIUM SULFATE | Whole Foods Market | 709ad74e-d95d-409d-bd7a-185411fc4bac | 2026-10-06 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Harris Teeter, LLC | f55da148-81a3-49cc-bbde-6aef920b8903 | 2026-10-05 | Warnings | DE08037SAB |
| Epsom Salt | EPSOM SALT | Strategic Sourcing Services LLC | cfe04d1a-2a7d-48bd-876f-93a7c6186ba3 | 2026-10-02 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Safeway, Inc. | 947ae6fe-05d9-4bcf-be73-b3e1a2c60227 | 2026-10-02 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | TOP CARE (Topco Associates LLC) | b1222ba6-390d-478d-905b-994fff4d6d58 | 2026-10-02 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | WinCo Foods, LLC | 80e420c5-7e1f-4c62-b914-f607767fd239 | 2026-10-01 | Warnings | DE08037SAB |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | 88edb3fc-fcb6-4483-859d-f830b077aca2 | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | 2a7300d3-95e3-427e-bf37-55fa654cc90a | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | dc56c264-d10e-4059-b0d5-2feff16b345d | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Cardinal Health 107, LLC | 5ba67321-6988-46ea-97a0-549954e2c405 | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral | SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL | Macleods Pharmaceuticals Limited | e56e8f90-51f5-4f51-9b6b-a6f5a2e499cc | 2026-09-18 | Warnings, Adverse reactions | DE08037SAB |
| Olanzapine | OLANZAPINE | PD-Rx Pharmaceuticals, Inc. | 10043041-a632-4e57-bc08-37216dea8546 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Apotex Corp. | 96165590-b287-0ed9-3723-752af59aedad | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | b7f27239-c22e-46d4-a313-50270cc19445 | 2026-09-14 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.